267 related articles for article (PubMed ID: 23864062)
41. Diffusion-weighted magnetic resonance imaging in the differentiation of angiomyolipoma with minimal fat from clear cell renal cell carcinoma.
Tanaka H; Yoshida S; Fujii Y; Ishii C; Tanaka H; Koga F; Saito K; Masuda H; Kawakami S; Kihara K
Int J Urol; 2011 Oct; 18(10):727-30. PubMed ID: 21815937
[TBL] [Abstract][Full Text] [Related]
42. Dual-tracer PET/CT in renal angiomyolipoma and subtypes of renal cell carcinoma.
Ho CL; Chen S; Ho KM; Chan WK; Leung YL; Cheng KC; Wong KN; Cheung MK; Wong KK
Clin Nucl Med; 2012 Nov; 37(11):1075-82. PubMed ID: 22996247
[TBL] [Abstract][Full Text] [Related]
43. Chemical shift magnetic resonance imaging for distinguishing minimal-fat renal angiomyolipoma from renal cell carcinoma: a meta-analysis.
Chen LS; Zhu ZQ; Wang ZT; Li J; Liang LF; Jin JY; Wang ZQ
Eur Radiol; 2018 May; 28(5):1854-1861. PubMed ID: 29178029
[TBL] [Abstract][Full Text] [Related]
44. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
[TBL] [Abstract][Full Text] [Related]
45. Angiomyolipoma: imaging findings in lesions with minimal fat.
Jinzaki M; Tanimoto A; Narimatsu Y; Ohkuma K; Kurata T; Shinmoto H; Hiramatsu K; Mukai M; Murai M
Radiology; 1997 Nov; 205(2):497-502. PubMed ID: 9356635
[TBL] [Abstract][Full Text] [Related]
46. Diagnostic value of multidetector computed tomography for renal sinus fat invasion in renal cell carcinoma patients.
Kim C; Choi HJ; Cho KS
Eur J Radiol; 2014 Jun; 83(6):914-918. PubMed ID: 24713489
[TBL] [Abstract][Full Text] [Related]
47. Can Quantitative CT Texture Analysis be Used to Differentiate Fat-poor Renal Angiomyolipoma from Renal Cell Carcinoma on Unenhanced CT Images?
Hodgdon T; McInnes MD; Schieda N; Flood TA; Lamb L; Thornhill RE
Radiology; 2015 Sep; 276(3):787-96. PubMed ID: 25906183
[TBL] [Abstract][Full Text] [Related]
48. Renal Cell Carcinoma: Accuracy of Multidetector Computed Tomography in the Assessment of Renal Sinus Fat Invasion.
Bolster F; Durcan L; Barrett C; Lawler LP; Cronin CG
J Comput Assist Tomogr; 2016; 40(6):851-855. PubMed ID: 27331926
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of T1-Weighted MRI to Detect Intratumoral Hemorrhage Within Papillary Renal Cell Carcinoma as a Feature Differentiating From Angiomyolipoma Without Visible Fat.
Murray CA; Quon M; McInnes MD; van der Pol CB; Hakim SW; Flood TA; Schieda N
AJR Am J Roentgenol; 2016 Sep; 207(3):585-91. PubMed ID: 27275530
[TBL] [Abstract][Full Text] [Related]
50. Subtype differentiation of small renal cell carcinomas on three-phase MDCT: usefulness of the measurement of degree and heterogeneity of enhancement.
Jung SC; Cho JY; Kim SH
Acta Radiol; 2012 Feb; 53(1):112-8. PubMed ID: 22114020
[TBL] [Abstract][Full Text] [Related]
51. MDCT findings of pancreatic metastases according to primary tumors.
Choi TW; Kim SH; Shin CI; Han JK; Choi BI
Abdom Imaging; 2015 Aug; 40(6):1595-607. PubMed ID: 25427986
[TBL] [Abstract][Full Text] [Related]
52. C-kit expression in renal oncocytomas and chromophobe renal cell carcinomas.
Huo L; Sugimura J; Tretiakova MS; Patton KT; Gupta R; Popov B; Laskin WB; Yeldandi A; Teh BT; Yang XJ
Hum Pathol; 2005 Mar; 36(3):262-8. PubMed ID: 15791570
[TBL] [Abstract][Full Text] [Related]
53. Differentiation of fat-poor angiomyolipoma from clear cell renal cell carcinoma in contrast-enhanced MDCT images using quantitative feature classification.
Lee HS; Hong H; Jung DC; Park S; Kim J
Med Phys; 2017 Jul; 44(7):3604-3614. PubMed ID: 28376281
[TBL] [Abstract][Full Text] [Related]
54. [MR imaging features of different renal cell carcinoma subtypes].
Wu B; Peng WJ; Gu YJ; Yang TX; Jiang ZX; Zhang HL; Dai B; Ye DW; Kong YY; Du X
Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):825-30. PubMed ID: 19173827
[TBL] [Abstract][Full Text] [Related]
55. [Differential diagnosis between renal cell carcinoma associated with XP11.2 translocation/TFE gene fusion and papillary renal cell carcinoma based on CT and MRI findings].
Zhu Q; Zhu W; Wu J; Fu J; Chen W; Wang Z
Zhonghua Yi Xue Za Zhi; 2014 May; 94(19):1470-2. PubMed ID: 25143166
[TBL] [Abstract][Full Text] [Related]
56. Unusual fat-containing tumors of the kidney: a diagnostic dilemma.
Hélénon O; Merran S; Paraf F; Melki P; Correas JM; Chrétien Y; Moreau JF
Radiographics; 1997; 17(1):129-44. PubMed ID: 9017804
[TBL] [Abstract][Full Text] [Related]
57. Differentiation of renal oncocytoma and renal clear cell carcinoma using relative CT enhancement ratio.
Ren A; Cai F; Shang YN; Ma ES; Huang ZG; Wang W; Lu Y; Zhang XZ
Chin Med J (Engl); 2015 Jan; 128(2):175-9. PubMed ID: 25591558
[TBL] [Abstract][Full Text] [Related]
58. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
59. Qualitative and quantitative CECT features for differentiating renal primitive neuroectodermal tumor from the renal cell carcinoma and its subtypes.
Kumar P; Singh A; Deshmukh A; Phulware RH; Rastogi S; Barwad A; Chandrashekhara SH; Singh V
Br J Radiol; 2019 Feb; 92(1094):20180738. PubMed ID: 30362816
[TBL] [Abstract][Full Text] [Related]
60. Dynamic computed tomography and Doppler findings in different subtypes of renal cell carcinoma with their histopathological correlation.
Sureka B; Lal A; Khandelwal N; Joshi K; Singh SK; Agarwal MM; Mittal A
J Cancer Res Ther; 2014; 10(3):552-7. PubMed ID: 25313738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
